{"transactions":[{"id":2225842,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":126016,"kind":"person","name":"MILLIGAN DAVID V","position":1,"cik":"0001222252","reported_name":"MILLIGAN DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-06-21T10:30:25.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":9470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date."}],"balance_after":9470,"derivative":{"exercise_price":65.06,"expiration_date":"2025-06-16","underlying":"Common Stock","underlying_shares":9470},"source":{"system":"sec-edgar","filing":"0000899243-22-023233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322023233/doc4.xml","form_type":"4"}},{"id":2661592,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":126016,"kind":"person","name":"MILLIGAN DAVID V","position":1,"cik":"0001222252","reported_name":"MILLIGAN DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2021-06-21T12:02:09.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":12489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date."}],"balance_after":12489,"derivative":{"exercise_price":105.08,"expiration_date":"2024-06-17","underlying":"Common Stock","underlying_shares":12489},"source":{"system":"sec-edgar","filing":"0000899243-21-024666","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924321024666/doc4.xml","form_type":"4"}},{"id":3105750,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":126016,"kind":"person","name":"MILLIGAN DAVID V","position":1,"cik":"0001222252","reported_name":"MILLIGAN DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-06-18T11:43:51.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date."}],"balance_after":6000,"derivative":{"exercise_price":111.06,"expiration_date":"2025-06-17","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-20-016987","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320016987/doc4.xml","form_type":"4"}},{"id":3246598,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":126016,"kind":"person","name":"MILLIGAN DAVID V","position":1,"cik":"0001222252","reported_name":"MILLIGAN DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-26T23:06:47.000Z","date":"2018-11-19","kind":"sale","acquired":false,"shares":10000,"price":131.6,"value":1316000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-20-005946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320005946/doc4.xml","form_type":"4"}},{"id":3246596,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":126016,"kind":"person","name":"MILLIGAN DAVID V","position":1,"cik":"0001222252","reported_name":"MILLIGAN DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-26T22:41:39.000Z","date":"2018-11-21","kind":"sale","acquired":false,"shares":20000,"price":112.54,"value":2250800.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-005924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320005924/doc4.xml","form_type":"4"}},{"id":3474909,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":126016,"kind":"person","name":"MILLIGAN DAVID V","position":1,"cik":"0001222252","reported_name":"MILLIGAN DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-01T21:13:38.000Z","date":"2019-06-27","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date."}],"balance_after":10000,"derivative":{"exercise_price":100.45,"expiration_date":"2024-06-27","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-018628","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924319018628/doc4.xml","form_type":"4"}},{"id":3765256,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":126016,"kind":"person","name":"MILLIGAN DAVID V","position":1,"cik":"0001222252","reported_name":"MILLIGAN DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-14T23:43:03.000Z","date":"2018-11-14","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":16.46,"exercise_date":"2018-06-29","expiration_date":"2027-06-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-18-012858","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000117911018012858/edgar.xml","form_type":"4"}},{"id":3765255,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":126016,"kind":"person","name":"MILLIGAN DAVID V","position":1,"cik":"0001222252","reported_name":"MILLIGAN DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-14T23:43:03.000Z","date":"2018-11-14","kind":"exercise","acquired":true,"shares":10000,"price":16.46,"value":164600.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001179110-18-012858","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000117911018012858/edgar.xml","form_type":"4"}},{"id":3811866,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":126016,"kind":"person","name":"MILLIGAN DAVID V","position":1,"cik":"0001222252","reported_name":"MILLIGAN DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-19T20:25:06.000Z","date":"2018-09-18","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.45,"exercise_date":"2017-07-22","expiration_date":"2026-07-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001179110-18-011555","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000117911018011555/edgar.xml","form_type":"4"}},{"id":3811865,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":126016,"kind":"person","name":"MILLIGAN DAVID V","position":1,"cik":"0001222252","reported_name":"MILLIGAN DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-19T20:25:06.000Z","date":"2018-09-18","kind":"exercise","acquired":true,"shares":20000,"price":9.45,"value":189000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001179110-18-011555","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000117911018011555/edgar.xml","form_type":"4"}},{"id":3886222,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":126016,"kind":"person","name":"MILLIGAN DAVID V","position":1,"cik":"0001222252","reported_name":"MILLIGAN DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-21T23:00:42.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date."}],"balance_after":10000,"derivative":{"exercise_price":303.79,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-18-008927","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000117911018008927/edgar.xml","form_type":"4"}},{"id":4269443,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":126016,"kind":"person","name":"MILLIGAN DAVID V","position":1,"cik":"0001222252","reported_name":"MILLIGAN DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-30T22:01:36.000Z","date":"2017-06-29","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 100% on the first anniversary of the date of grant, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date."}],"balance_after":10000,"derivative":{"exercise_price":16.46,"expiration_date":"2027-06-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-17-009846","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000117911017009846/edgar.xml","form_type":"4"}},{"id":4566744,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":126016,"kind":"person","name":"MILLIGAN DAVID V","position":1,"cik":"0001222252","reported_name":"MILLIGAN DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-04T21:17:40.000Z","date":"2016-07-22","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This report amends the original report to reflect the correct exercise price of $9.45 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fifty percent (50%) of the option vests on July 22, 2017 and thereafter it vests at a rate of twelve and one-half percent (12.5%) per quarter for four (4) consecutive quarters."}],"balance_after":20000,"derivative":{"exercise_price":9.45,"expiration_date":"2026-07-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001179110-16-031251","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000117911016031251/edgar.xml","form_type":"4/A","original_submission_date":"2016-10-24"}},{"id":4575728,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":126016,"kind":"person","name":"MILLIGAN DAVID V","position":1,"cik":"0001222252","reported_name":"MILLIGAN DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-24T23:08:53.000Z","date":"2016-07-22","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the option vests on July 22, 2017 and thereafter it vests at a rate of twelve and one-half percent (12.5%) per quarter for four (4) successive quarters.  The filing is late due to an administrative oversight."}],"balance_after":20000,"derivative":{"exercise_price":12.01,"expiration_date":"2026-07-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001179110-16-030884","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000117911016030884/edgar.xml","form_type":"4"}}]}